Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 10 search results for "Imfinzi" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Does Immunotherapy for Lung Cancer Work?
... Two major clinical trials found that the combination of Tecentriq or Imfinzi with etoposide and platinum-based chemotherapies improved overall survival. Talk With Others Who UnderstandMyLungCancerTeam is the social network for people with lung cancer and their loved ones. ...
Does Immunotherapy for Lung Cancer Work?
... Two major clinical trials found that the combination of Tecentriq or Imfinzi with etoposide and platinum-based chemotherapies improved overall survival. Talk With Others Who UnderstandMyLungCancerTeam is the social network for people with lung cancer and their loved ones. ...
COVID-19 Vaccine Boosters and Additional Doses for People With Lung Cancer: Current Guidelines
... Immunotherapy medications for lung cancer include:Opdivo (nivolumab)Libtayo (cemiplimab)Keytruda (pembrolizumab)Tecentriq (atezolizumab)Imfinzi (durvalumab)Yervoy (ipilimumab)Chemotherapies used to treat lung cancer include:CarboplatinCisplatinTaxotere (docetaxel)Taxol (paclitaxel)Gemzar (gemcitabine)Alimta (pemetrexed)Navelbine (vinorelbine)The American ...
Posted 09/24/2021
COVID-19 Vaccine Boosters and Additional Doses for People With Lung Cancer: Current Guidelines
... Immunotherapy medications for lung cancer include:Opdivo (nivolumab)Libtayo (cemiplimab)Keytruda (pembrolizumab)Tecentriq (atezolizumab)Imfinzi (durvalumab)Yervoy (ipilimumab)Chemotherapies used to treat lung cancer include:CarboplatinCisplatinTaxotere (docetaxel)Taxol (paclitaxel)Gemzar (gemcitabine)Alimta (pemetrexed)Navelbine (vinorelbine)The American ...
Posted 09/24/2021
Health Care Inequity, Treatment Advances Among Research Highlights at World Conference on Lung Cancer
... One clinical trial found that when the targeted therapy drugs durvalumab (sold under the brand name Imfinzi) and tremelimumab were added to chemotherapy, people with stage 4 non-small cell lung cancer (NSCLC) lived longer and didn’t experience relapses as quickly. ...
Posted 10/22/2021
Health Care Inequity, Treatment Advances Among Research Highlights at World Conference on Lung Cancer
... One clinical trial found that when the targeted therapy drugs durvalumab (sold under the brand name Imfinzi) and tremelimumab were added to chemotherapy, people with stage 4 non-small cell lung cancer (NSCLC) lived longer and didn’t experience relapses as quickly. ...
Posted 10/22/2021
GLP-1 Drugs and Lung Cancer: Are They Safe To Take?
... Centers for Disease Control and Prevention Obesity — Cleveland Clinic Diabetes Basics — Centers for Disease Control and Prevention Prescription Medications to Treat Overweight & Obesity — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Zepbound — Eli Lilly and Company Common Cancer Types — National Cancer Institute Durvalumab (Imfinzi ...
GLP-1 Drugs and Lung Cancer: Are They Safe To Take?
... Centers for Disease Control and Prevention Obesity — Cleveland Clinic Diabetes Basics — Centers for Disease Control and Prevention Prescription Medications to Treat Overweight & Obesity — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Zepbound — Eli Lilly and Company Common Cancer Types — National Cancer Institute Durvalumab (Imfinzi ...
Immunotherapy for Lung Cancer: 4 Types and How They Work
... Food and Drug Administration (FDA) has approved four PD-1/PD-L1 inhibitors to treat advanced non-small cell lung cancer (NSCLC): Pembrolizumab (Keytruda) Cemiplimab-rwlc (Libtayo) Nivolumab (Opdivo) Atezolizumab (Tecentriq) The FDA has also approved a PD-L1 inhibitor called durvalumab (Imfinzi) for treating both advanced small cell lung cancer (SCLC ...
Immunotherapy for Lung Cancer: 4 Types and How They Work
... Food and Drug Administration (FDA) has approved four PD-1/PD-L1 inhibitors to treat advanced non-small cell lung cancer (NSCLC): Pembrolizumab (Keytruda) Cemiplimab-rwlc (Libtayo) Nivolumab (Opdivo) Atezolizumab (Tecentriq) The FDA has also approved a PD-L1 inhibitor called durvalumab (Imfinzi) for treating both advanced small cell lung cancer (SCLC ...
NSCLC Treatment Options: First-Line Treatments and Beyond
... Examples include: Atezolizumab (Tecentriq) Cemiplimab (Libtayo) Durvalumab (Imfinzi) Nivolumab (Opdivo) Pembrolizumab (Keytruda) CTLA-4 inhibitors are another type of immune checkpoint inhibitor that works by blocking the CTLA-4 protein. These medications are always combined with a PD-1 inhibitor, with or without chemotherapy. ...
NSCLC Treatment Options: First-Line Treatments and Beyond
... Examples include: Atezolizumab (Tecentriq) Cemiplimab (Libtayo) Durvalumab (Imfinzi) Nivolumab (Opdivo) Pembrolizumab (Keytruda) CTLA-4 inhibitors are another type of immune checkpoint inhibitor that works by blocking the CTLA-4 protein. These medications are always combined with a PD-1 inhibitor, with or without chemotherapy. ...
What Is Advanced NSCLC? Symptoms, Treatment, Stages, and More
... Some immunotherapy drugs are also known as checkpoint inhibitors because they interfere with molecules in the immune system that block the body from attacking cancer cells.Immunotherapy drugs for NSCLC include: Atezolizumab (Tecentriq) Cemiplimab-rwlc (Libtayo) Durvalumab (Imfinzi) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Targeted TherapyTargeted ...
What Is Advanced NSCLC? Symptoms, Treatment, Stages, and More
... Some immunotherapy drugs are also known as checkpoint inhibitors because they interfere with molecules in the immune system that block the body from attacking cancer cells.Immunotherapy drugs for NSCLC include: Atezolizumab (Tecentriq) Cemiplimab-rwlc (Libtayo) Durvalumab (Imfinzi) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Targeted TherapyTargeted ...
New Lung Cancer Treatments: 9 Advancements in Research
... This is a treatment option for people who can’t be treated with surgery or chemoradiation (chemotherapy and radiation therapy together).The FDA also approved the combination of tremelimumab (Imjudo) with durvalumab (Imfinzi) and chemotherapy for people with metastatic (stage 4) NSCLC. ...
New Lung Cancer Treatments: 9 Advancements in Research
... This is a treatment option for people who can’t be treated with surgery or chemoradiation (chemotherapy and radiation therapy together).The FDA also approved the combination of tremelimumab (Imjudo) with durvalumab (Imfinzi) and chemotherapy for people with metastatic (stage 4) NSCLC. ...
5 Treatment Types for Advanced NSCLC
... These monoclonal antibodies target CTLA-4, a protein that blocks T-cell activity.Checkpoint inhibitors that are used to treat advanced NSCLC include: Atezolizumab (Tecentriq), which targets PD-L1 Cemiplimab (Libtayo), which targets PD-L1 Durvalumab (Imfinzi), which targets PD-L1 Ipilimumab (Yervoy), which targets CTLA-4 Nivolumab (Opdivo), which targets ...
5 Treatment Types for Advanced NSCLC
... These monoclonal antibodies target CTLA-4, a protein that blocks T-cell activity.Checkpoint inhibitors that are used to treat advanced NSCLC include: Atezolizumab (Tecentriq), which targets PD-L1 Cemiplimab (Libtayo), which targets PD-L1 Durvalumab (Imfinzi), which targets PD-L1 Ipilimumab (Yervoy), which targets CTLA-4 Nivolumab (Opdivo), which targets ...
Biomarkers for Lung Cancer: 12 Things To Know
... Drugs used include: Atezolizumab (Tecentriq) Cemiplimab-rwlc (Libtayo) Durvalumab (Imfinzi) Ipilimumab (Yervoy) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Tremelimumab (Imjudo) A higher PD-L1 level often means a greater chance that immunotherapy will shrink or control the cancer.11. ...
Biomarkers for Lung Cancer: 12 Things To Know
... Drugs used include: Atezolizumab (Tecentriq) Cemiplimab-rwlc (Libtayo) Durvalumab (Imfinzi) Ipilimumab (Yervoy) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Tremelimumab (Imjudo) A higher PD-L1 level often means a greater chance that immunotherapy will shrink or control the cancer.11. ...